Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Kenji Tanabe, M.D.

Co-Author

This page shows the publications co-authored by Kenneth Tanabe and Martin Mihm.
Connection Strength

0.522
  1. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007 Aug 01; 110(3):614-24.
    View in: PubMed
    Score: 0.093
  2. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005 Sep 20; 23(27):6739-46.
    View in: PubMed
    Score: 0.082
  3. A case-control study of desmoplastic melanoma. J Clin Oncol. 2005 Jun; 23(16_suppl):7529.
    View in: PubMed
    Score: 0.080
  4. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999 Apr; 134(4):381-7.
    View in: PubMed
    Score: 0.052
  5. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol. 2013 Jan; 44(1):87-94.
    View in: PubMed
    Score: 0.033
  6. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death. Cancer. 2009 Nov 01; 115(21):5071-83.
    View in: PubMed
    Score: 0.027
  7. Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer. 2009 Nov 01; 115(21):5084-94.
    View in: PubMed
    Score: 0.027
  8. How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer. 2009 Nov 01; 115(21):5095-107.
    View in: PubMed
    Score: 0.027
  9. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg. 2004 Apr; 139(4):400-4; discussion 404-5.
    View in: PubMed
    Score: 0.018
  10. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. J Clin Oncol. 2003 Sep 01; 21(17):3343-50.
    View in: PubMed
    Score: 0.018
  11. Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J. 2000 May-Jun; 6(3):139-45.
    View in: PubMed
    Score: 0.014
  12. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999 Aug 15; 86(4):617-27.
    View in: PubMed
    Score: 0.013
  13. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A. 1998 Oct 27; 95(22):13141-6.
    View in: PubMed
    Score: 0.013
  14. Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg. 1997 May; 225(5):544-50; discussion 550-3.
    View in: PubMed
    Score: 0.011
  15. A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor. Hum Gene Ther. 1997 Jan 01; 8(1):111-23.
    View in: PubMed
    Score: 0.011
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.